mRNA |
Parthenolide |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.03 |
mRNA |
phloretin |
CTRPv2 |
pan-cancer |
AAC |
0.072 |
0.03 |
mRNA |
TW 37 |
GDSC1000 |
pan-cancer |
AAC |
-0.069 |
0.03 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.075 |
0.04 |
mRNA |
AG-014699 |
GDSC1000 |
pan-cancer |
AAC |
-0.07 |
0.04 |
mRNA |
MLN4924 |
GDSC1000 |
pan-cancer |
AAC |
-0.082 |
0.04 |
mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.04 |
mRNA |
Gemcitabine |
GDSC1000 |
pan-cancer |
AAC |
-0.072 |
0.04 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.073 |
0.04 |
mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
-0.1 |
0.05 |